Search Results - "Stevenson, James G."

Refine Results
  1. 1

    Cost Analysis of Implementing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Plus Real-Time Antimicrobial Stewardship Intervention for Bloodstream Infections by Patel, Twisha S, Kaakeh, Rola, Nagel, Jerod L, Newton, Duane W, Stevenson, James G

    Published in Journal of clinical microbiology (01-01-2017)
    “…Studies evaluating rapid diagnostic testing plus stewardship intervention have consistently demonstrated improved clinical outcomes for patients with…”
    Get full text
    Journal Article
  2. 2

    Biosimilars: Implications for health-system pharmacists by LUCIO, STEVEN D, STEVENSON, JAMES G, HOFFMAN, JAMES M

    Published in American journal of health-system pharmacy (15-11-2013)
    “…PURPOSEAn update on scientific and regulatory challenges in the rapidly evolving field of biosimilar product development is presented. SUMMARYThe U.S. market…”
    Get full text
    Journal Article
  3. 3

    Oseltamivir for pandemic influenza preparation: Maximizing the use of an existing stockpile by Patel, Twisha S., PharmD, Cinti, Sandro, MD, Sun, Duxin, PhD, Li, Siwei, PhD, Luo, Ruijuan, PhD, Wen, Bo, PhD, Gallagher, Brian A., JD, Stevenson, James G., PharmD

    Published in American journal of infection control (01-03-2017)
    “…Highlights • To mitigate cost, shelf-life extension with rotating inventory should be considered. • Tested lots were within the USP acceptance criteria of…”
    Get full text
    Journal Article
  4. 4

    Patient-centered medical home: Developing, expanding, and sustaining a role for pharmacists by Choe, Hae Mi, Farris, Karen B, Stevenson, James G, Townsend, Kevin, Diez, Heidi L, Remington, Tami L, Rockafellow, Stuart, Shimp, Leslie A, Sy, Annie, Wells, Trisha, Standiford, Connie J

    Published in American journal of health-system pharmacy (15-06-2012)
    “…The development of a patient-centered medical home (PCMH) health care model and the role of pharmacists in PCMHs at the University of Michigan are described…”
    Get full text
    Journal Article
  5. 5

    Clinical decision support for atypical orders: detection and warning of atypical medication orders submitted to a computerized provider order entry system by Woods, Allie D, Mulherin, David P, Flynn, Allen J, Stevenson, James G, Zimmerman, Christopher R, Chaffee, Bruce W

    “…The specificity of medication-related alerts must be improved to overcome the pernicious effects of alert fatigue. A systematic comparison of new drug orders…”
    Get full text
    Journal Article
  6. 6

    Variability in compounding of oral liquids for pediatric patients: A patient safety concern by Rood, Janis M., PharmD, Engels, Melanie J., PharmD, Ciarkowski, Scott L., PharmD, MBA, Wagenknecht, Larry D., BSPharm, Dickinson, Chris J., MD, Stevenson, James G., PharmD, FASHP

    “…Abstract Objective To determine the degree in variation of oral liquid pediatric compounding practices in Michigan pharmacies. Design Cross-sectional survey…”
    Get full text
    Journal Article
  7. 7

    Evaluation of a transplantation specialty pharmacy program by Hlubocky, Jennifer M, Stuckey, Linda J, Schuman, Alice D, Stevenson, James G

    Published in American journal of health-system pharmacy (15-02-2012)
    “…The value of a transplantation specialty pharmacy (TSP) program, including its impact on patient and health care provider satisfaction, selected clinical…”
    Get full text
    Journal Article
  8. 8

    Pharmacist biosimilar survey reveals knowledge gaps by Stevenson, James G., McCabe, Dorothy, McGrath, Melissa, McBride, Ali

    “…Biosimilars are of increasing significance to pharmacy practice, with the potential to improve patient access to biologic therapies and help reduce overall…”
    Get full text
    Journal Article
  9. 9

    The global landscape on interchangeability of biosimilars by Rathore, Anurag S, Stevenson, James G, Chhabra, Hemlata, Maharana, Chinmoyee

    Published in Expert opinion on biological therapy (01-02-2022)
    “…Biosimilars hold the potential to be an integral healthcare component that can significantly improve affordability and thereby accessibility of the otherwise…”
    Get more information
    Journal Article
  10. 10

    Clinical data and regulatory issues of biosimilar products by Stevenson, James G

    Published in The American journal of managed care (01-12-2015)
    “…Biologics are a fast-growing segment of pharmaceutical development. Many are effective in the treatment of illnesses such as cancers, rheumatoid arthritis, and…”
    Get full text
    Journal Article
  11. 11

    Understanding the problem of digital medication inventory visibility in health systems by Ashemore, Arlin W, Akrap, Antonia, Aschermann, Lauren, Irvine, Clayton, Foley, Joshua, Scheper, John David, Tarpey, Ryan, Stevenson, James G

    Published in American journal of health-system pharmacy (07-09-2023)
    “…Abstract Purpose This project describes and quantifies the perceived degree of digital visibility to medication inventory throughout 6 large health systems…”
    Get full text
    Journal Article
  12. 12

    Considerations related to comparative clinical studies for biosimilars by Rathore, Anurag S, Stevenson, James G, Chhabra, Hemlata

    Published in Expert opinion on drug safety (04-03-2021)
    “…Biosimilar medicines have transformed the healthcare landscape by providing improved access to life-saving medicines at a lower cost. Biosimilars are a…”
    Get more information
    Journal Article
  13. 13

    Biosimilars: Practical Considerations for Pharmacists by Stevenson, James G., Popovian, Robert, Jacobs, Ira, Hurst, Susan, Shane, Lesley G.

    Published in Annals of Pharmacotherapy (01-07-2017)
    “…Objective: To review the scientific and regulatory aspects of biosimilar development and practical considerations for the use of biosimilars that are relevant…”
    Get full text
    Book Review Journal Article
  14. 14

    An analysis of hospital pharmacy practice in Namibia, based on FIP's Basel Statements by Bare, Andrea, Ivey, Marianne, Kibuule, Dan, Stevenson, James G

    “…Sub-Saharan Africa, a region faced with a double challenge of infectious and non-communicable diseases requires strengthening of hospital pharmacy practice to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Demonstrating the Value of Antimicrobial Stewardship Programs to Hospital Administrators by Nagel, Jerod L., Stevenson, James G., Eiland, Edward H., Kaye, Keith S.

    Published in Clinical infectious diseases (15-10-2014)
    “…The movement away from fee-for-service models to those that emphasize quality of care and patient outcomes affords a unique opportunity for antimicrobial…”
    Get full text
    Journal Article
  17. 17

    Factors associated with naloxone availability and dispensing through Michigan's pharmacy standing order by Dahlem, Chin Hwa, Myers, Matthew, Goldstick, Jason, Stevenson, James G., Gray, George, Rockhill, Sarah, Dora-Laskey, Aaron, Kellenberg, Joan, Brummett, Chad M., Kocher, Keith E.

    “…Background: Pharmacy standing order policies allow pharmacists to dispense naloxone, thereby increasing access to naloxone. Objectives: To describe pharmacy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Comparison of barcode scanning by pharmacy technicians and pharmacistsʼ visual checks for final product verification by Wang, Bryan Nian-Tsi, Brummond, Philip, Stevenson, James G

    Published in American journal of health-system pharmacy (15-01-2016)
    “…PURPOSE.The results of an evaluation of barcode verification by pharmacy technicians as an alternative to visual checking by pharmacists in the final stage of…”
    Get full text
    Journal Article
  20. 20

    A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial by Spaulding, Alicen, Fendrick, A Mark, Herman, William H, Stevenson, James G, Smith, Dean G, Chernew, Michael E, Parsons, Dawn M, Bruhnsen, Keith, Rosen, Allison B

    Published in Implementation science : IS (07-04-2009)
    “…Diabetes affects over 20 million Americans, resulting in substantial morbidity, mortality, and costs. While medications are the cornerstone of secondary…”
    Get full text
    Journal Article